A Study of Induction Dosing With PEGASYS (Peginterferon Alfa-2a [40KD]) Plus Copegus in Treatment-Naive Patients With Chronic Hepatitis C

NCT00394277 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1175

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: peginterferon alfa-2a
DRUG: Ribavirin
DRUG: peginterferon alfa-2a
DRUG: Ribavirin

Sponsor

Hoffmann-La Roche